(-)-Salinosporamide A, ML 858, NPI 0052, Marizomib
Salinosporamide A (NPI-0052, Marizomib) is a novel marine derived proteasome inhibitor which inhibits CT-L, C-L, and T-L proteasome activities in human erythrocyte-derived 20S proteasomes with EC50 of 3.5 nM, 430 nM, 28 nM.
Molecular Weight:
313.78
Purity:
>99.0%
CAS Number:
[437742-34-2]
Formula:
C15H20ClNO4
Target:
Proteasome
* VAT and and shipping costs not included. Errors and price changes excepted